A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
PHASE1
This study is an open-label, multi-center, dose-escalation, dose expansion ...
Status
Terminated
Location
The University of Arizona Cancer Center (UACC) - North Campus
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
PHASE1
This phase I trial tests the safety, side effects, and best dose of SM08502...